InvestorsHub Logo
icon url

vortmaximum

12/16/20 8:09 AM

#19790 RE: PennyWorld #19788

Amazing write up: There is strong clinical science behind the drug treating other diseases, and more recently, data to show that bucillamine could be a key treatment for coronavirus.

Additionally, a study released just last week by researchers at the University of California supports the hypothesis that thiol-based drugs like bucillamine can reduce the side effects associated with the virus.


Sprinkle the shrooms on top and PB is right, this could go parabolic to multiple dollars soon! RVVTF
icon url

RioDad

12/16/20 8:47 AM

#19796 RE: PennyWorld #19788

This Forbes article will garner Eyes and Buys. I see some 114k shares sold in Pre-market this morning.

I think that OwnSnap knew this article was coming.

Get to a dollar pps and drop the good news of Bucillamine trial for a 10 bagger...

Pretty good strategy for a CEO that some say is untrustworthy!
icon url

delta_penny

12/16/20 9:11 AM

#19806 RE: PennyWorld #19788

Wow Nice Forbes article. Revive / Buciilamine is getting noticed. 114k volume is the most I’ve seen for pre-market. Someone wanted in really bad.
icon url

mrfumbles

12/16/20 9:54 AM

#19835 RE: PennyWorld #19788

Random side bar: If you add a period after 'com' it removes all paywalls, at least it should. Some sites have caught on but others have not yet.

EX: https://www.forbes.com./sites/amandasiebert/2020/12/16/revive-therapeutics-the-psychedelics-company-working-on-a-covid-19-treatment/?sh=6a99c79971b0